Blog

A defining milestone of the 2010s was QCMD’s growing role in rapid-response EQA for emerging infectious diseases (e.g., Zika virus molecular EQA launched in 2016). Today, there are many ongoing schemes supporting

In March 2005, the first version of the online Participant Profile Area (known as ITEMS) went live. This software system has been developed to provide participating laboratories a major communication tool to

During the 2000s, QCMD evolved from a Europe-centric initiative into a global EQA organisation. Longitudinal EQA schemes such as for enteroviruses, HSV, chlamydia trachomatis, blood-borne viruses (HIV, HBV, HCV), or mycobacterium tuberculosis

QCMD was formally established in June 2001 as an independent, not-for-profit organisation run by experts from the field to continue and expand those EU-funded activities internationally by providing structured EQA schemes for

A major milestone came with the launch of the EU supported Quality Control Concerted Action (EU-QCCA) project in 1998. This expanded earlier work beyond viral infections of the central nervous system into

In June 2011, QCMD has been accredited for the first time to ISO 17043 as a provider of proficiency testing schemes by UKAS. So far, QCMD’s quality management system was certified to

Today QCMD: runs 100+ molecular EQA schemes for infectious diseases serves laboratories in 120+ countries supports >15,000 participant registrations annually builds on a wide network of experts (individually or through national and